---
title: Mitragynine inhibits hippocampus neuroplasticity and its molecular mechanism
date: '2023-11-04'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37924443/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231105170822&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSION: Findings from this work reveal that a smaller dose of MIT
  (1 mg/kg) poses no risk to hippocampal synaptic transmission. Alteration in neuroplasticity-associated
  proteins may be a molecular mechanism for MIT (5 and 10 mg/kg)-induced LTP disruption
  and cognitive impairments. Data from this work posit that MIT acted differently
  from MOR on neuroplasticity and its underlying ...'
disable_comments: true
---
CONCLUSION: Findings from this work reveal that a smaller dose of MIT (1 mg/kg) poses no risk to hippocampal synaptic transmission. Alteration in neuroplasticity-associated proteins may be a molecular mechanism for MIT (5 and 10 mg/kg)-induced LTP disruption and cognitive impairments. Data from this work posit that MIT acted differently from MOR on neuroplasticity and its underlying ...